Noninvasive diagnosis of compensated cirrhosis using an analysis of the time-intensity curve portal vein slope gradient on contrast-enhanced ultrasonography

被引:6
作者
Goto, Yuichi [1 ]
Okuda, Koji [1 ]
Akasu, Gen [1 ]
Kinoshita, Hisafumi [1 ]
Tanaka, Hiroyuki [1 ]
机构
[1] Kurume Univ, Dept Surg, Div Hepatobiliary & Pancreat Surg, Kurume, Fukuoka 8300011, Japan
关键词
Diagnosis; Compensated cirrhosis; Contrast-enhanced ultrasonography; Time-intensity curve; Portal vein; CHRONIC HEPATITIS-C; TRANSIT-TIME; LIVER-CIRRHOSIS; ULTRASOUND; AGENT; METASTASES; FIBROSIS; DISEASE; PREDICT; HYPERTENSION;
D O I
10.1007/s00595-013-0750-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
We measured the slope gradients (SGs) of the vascular time-intensity curves (TICs) of the intrahepatic vessels on contrast-enhanced ultrasonography (CEUS). The aim of this study was to assess the diagnostic accuracy of the SG of each hepatic vessel, particularly the portal vein (PV), for detecting cirrhosis and to compare this method with conventional modalities. Fifty-one preoperative patients underwent CEUS, and the TICs were plotted. The SGs of the hepatic artery, PV and hepatic vein were obtained from the linear functions between the slope of the arrival time of the contrast agent and the peak enhancement time of each vessel. The transit times and levels of biochemical markers were also measured. The patients were divided into three groups according to the Metavir score: F0/1 group (n = 14), F2/3 group (n = 21) and F4 group (n = 16). The PVSG significantly decreased in the F4 group (F0/1: 29.1 +/- A 2.27, F2/3: 23.1 +/- A 1.86, F4: 14.7 +/- A 2.13). The PVSG demonstrated high accuracy for diagnosing cirrhosis and was correlated with the levels of ICG-R15 and hyaluronic acid (Spearman rank correlation; rho = -0.5691, p < 0.001 and rho = -0.4652, p = 0.0006). The PVSG has the potential to be a diagnostic marker for identifying patients with well-compensated cirrhosis.
引用
收藏
页码:1496 / 1505
页数:10
相关论文
共 27 条
[1]   Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent [J].
Albrecht, T ;
Blomley, MJK ;
Cosgrove, DO ;
Taylor-Robinson, SD ;
Jayaram, V ;
Eckersley, R ;
Urbank, A ;
Butler-Barnes, J ;
Patel, N .
LANCET, 1999, 353 (9164) :1579-1583
[2]  
BAGGENSTOSS AH, 1952, GASTROENTEROLOGY, V22, P157
[3]   Hepatic vein transit time of an ultrasound contrast agent: simplified procedure using pulse inversion imaging [J].
Bang, N ;
Nielsen, MB ;
Rasmussen, AN ;
Osterhammel, PA ;
Pedersen, JF .
BRITISH JOURNAL OF RADIOLOGY, 2001, 74 (884) :752-755
[4]   Hepatic transit time of an ultrasound echo enhancer indicating the presence of liver metastases -: First clinical results [J].
Bernatik, T ;
Strobel, D ;
Häusler, J ;
Wein, A ;
Hahn, EG ;
Becker, D .
ULTRASCHALL IN DER MEDIZIN, 2002, 23 (02) :91-95
[5]   Stimulated acoustic emission to image a late liver and spleen-specific phase of Levovist® in normal volunteers and patients with and without liver disease [J].
Blomley, MJK ;
Albrecht, T ;
Cosgrove, DO ;
Eckersley, RJ ;
Butler-Barnes, J ;
Jayaram, V ;
Patel, N ;
Heckemann, RA ;
Bauer, A ;
Schlief, R .
ULTRASOUND IN MEDICINE AND BIOLOGY, 1999, 25 (09) :1341-1352
[6]   Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study [J].
Blomley, MJK ;
Lim, AKP ;
Harvey, CJ ;
Patel, N ;
Eckersley, RJ ;
Basilico, R ;
Heckemann, R ;
Urbank, A ;
Cosgrove, DO ;
Taylor-Robinson, SD .
GUT, 2003, 52 (08) :1188-1193
[7]   Current concepts: Liver biopsy. [J].
Bravo, AA ;
Sheth, SG ;
Chopra, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) :495-500
[8]  
Broide E, 1997, Liver Transpl Surg, V3, P604
[9]  
Cichoz-Lach H, 2008, J PHYSIOL PHARMACOL, V59, P231
[10]   Intrahepatic circulatory time analysis of an ultrasound contrast agent in liver cirrhosis [J].
Hirota, M ;
Kaneko, T ;
Sugimoto, H ;
Kure, S ;
Inoue, S ;
Takeda, S ;
Nakao, A .
LIVER INTERNATIONAL, 2005, 25 (02) :337-342